|
Volumn 19, Issue 6, 2008, Pages 942-947
|
Impact of treatment with oral calcitriol on glucose intolerance and dyslipidemia(s) in hemodialysis patients.
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCITRIOL;
VITAMIN;
ADULT;
ARTICLE;
BLOOD;
CHRONIC KIDNEY FAILURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DYSLIPIDEMIA;
FEMALE;
GLUCOSE BLOOD LEVEL;
GLUCOSE INTOLERANCE;
HUMAN;
MALE;
METABOLISM;
MIDDLE AGED;
PANCREAS ISLET BETA CELL;
PATHOPHYSIOLOGY;
RANDOMIZED CONTROLLED TRIAL;
RENAL REPLACEMENT THERAPY;
ADULT;
BLOOD GLUCOSE;
CALCITRIOL;
DYSLIPIDEMIAS;
FEMALE;
GLUCOSE INTOLERANCE;
HUMANS;
INSULIN-SECRETING CELLS;
KIDNEY FAILURE, CHRONIC;
MALE;
MIDDLE AGED;
RENAL DIALYSIS;
VITAMINS;
|
EID: 59649113555
PISSN: 13192442
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (22)
|
References (0)
|